Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD
Ying Ding, … , David Klatzmann, Thomas R. Malek
Ying Ding, … , David Klatzmann, Thomas R. Malek
Published August 7, 2025
Citation Information: JCI Insight. 2025;10(18):e183676. https://doi.org/10.1172/jci.insight.183676.
View: Text | PDF
Research Article Immunology

BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD

  • Text
  • PDF
Abstract

Regulatory T cells (Tregs) are essential for peripheral tolerance and depend on TCR and IL-2 receptor (IL-2R) signaling for their homeostasis and function. In mice, IL-2–dependent B-lymphocyte-induced maturation protein 1 (BLIMP-1) contributes to Treg homeostasis. BLIMP-1 is a major transcriptional hub in human Tregs, but its mechanisms of action remain undefined. Here, using CRISPR/Cas9 ablation, we show that BLIMP-1 limits human Treg proliferation but supports IL-10, cytotoxic T lymphocyte-associated protein 4, several immune checkpoints including carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), and Treg functional activity. BLIMP-1 restrains Treg expansion to IL-2 by downregulating CD25 and IL-2R signaling, and by enhancing CEACAM1 expression, which in turn inhibits responsiveness to CD3/CD28 signaling and activation of mTOR. Prolonged IL-2R signaling optimizes BLIMP-1 expression, supporting chromosomal opening of CEACAM1 to increased CEACAM1 expression through STAT5- and BLIMP-1–driven enhancers. Correspondingly, CEACAM1 is highly induced on Tregs from patients with autoimmune disease undergoing low-dose IL-2 therapy, and these Tregs showed reduced proliferation. A humanized mouse model of xenogeneic graft-versus-host disease demonstrates that BLIMP-1 normally promotes, while CEACAM1 restrains, Treg suppressive activity. Collectively, our findings reveal that BLIMP-1 and CEACAM1 function in an IL-2–dependent feedback loop to restrain Treg proliferation and affect suppressive function. CEACAM1 also acts as a highly selective biomarker of IL-2R signaling in human T cells.

Authors

Ying Ding, Aixin Yu, Milos Vujanac, Sabrina N. Copsel, Alejandro Moro, Luis Nivelo, Molly Dalzell, Nicolas Tchitchek, Michelle Rosenzwajg, Alejandro V. Villarino, Robert B. Levy, David Klatzmann, Thomas R. Malek

×

Figure 3

BLIMP-1 is required for optimal Treg function.

Options: View larger image (or click on image) Download as PowerPoint
BLIMP-1 is required for optimal Treg function.
(A–C) At 7 days after tra...
(A–C) At 7 days after transfection with Cas9 RNP, the indicated Tregs were stimulated with anti-CD3/CD28 and IL-2 and assayed 16 hours later. (A) FOXP3 and HELIOS expression by flow cytometry (n = 6). (B) RNA expression by RNA-Seq of the indicated transcripts (n = 4). RNA data are expressed as transcripts/million (TPM). (C) PD1 and CTLA4 expression by flow cytometry (n = 6). (D) IL-10 secretion quantified by ELISA after PMA and ionomycin stimulation on day 7 posttransfection (n = 4). (E) In vitro suppression assay with control and PRDM1KO Tregs (n = 3). (F–I) Effect of PRDM1KO Tregs on the development of xGVHD. Irradiated NSG mice were adoptively transferred with PBMCs to induce xGVHD or in combination with control scramble or with PRDM1KO Tregs, as indicated. xGVHD was assessed by weight loss (F), clinical scores (G), and overall survival (H) (n = 12 from 2 independent experiments). HSCT, hematopoietic stem cell transplantation. (I) Treg cell numbers in the blood were assessed at indicated time points after transplantation. Data are shown as the mean ± SEM and analyzed by a paired 2-tail t test (A–D), 2-way ANOVA with multiple comparisons (E), AUC with 1-way ANOVA with multiple comparisons (F and G), a log-rank (Mantel-Cox) test (H), or 1-way ANOVA with multiple comparisons (I). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts